Inhibition of the de-myelinating properties of Aicardi-Goutières Syndrome lymphocytes by cathepsin D silencing

A. Pulliero, B. Marengo, M. Longobardi, E. Fazzi, S. Orcesi, I. Olivieri, C. Cereda, C. Domenicotti, U. Balottin, A. Izzotti

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Molecular mechanisms relating interferon-alpha (IFN-alpha) to brain damage have recently been identified in a microarray analysis of cerebrospinal fluid lymphocytes from patients with Aicardi-Goutières Syndrome (AGS). These findings demonstrate that the inhibition of angiogenesis and the activation of neurotoxic lymphocytes are the major pathogenic mechanisms involved in the brain damage consequent to elevated interferon-alpha levels. Our previous study demonstrated that cathepsin D, a lysosomal aspartyl endopeptidase, is the primary mediator of the neurotoxicity exerted by AGS lymphocytes. Cathepsin D is a potent pro-apoptotic, neurotoxic, and demyelinating protease if it is not properly inhibited by the activities of leukocystatins. In central nervous system white matter, demyelination results from cathepsin over-expression when not balanced by the expression of its inhibitors. In the present study, we used RNA interference to inhibit cathepsin D expression in AGS lymphocytes with the aim of decreasing the neurotoxicity of these cells. Peripheral blood lymphocytes collected from an AGS patient were immortalized and co-cultured with astrocytes in the presence of interferon alpha with or without cathepsin D RNA interference probes. Cathepsin D expression was measured by qPCR, and neurotoxicity was evaluated by microscopy. RNA interference inhibited cathepsin D over-production by 2.6-fold (P

Original languageEnglish
Pages (from-to)957-962
Number of pages6
JournalBiochemical and Biophysical Research Communications
Volume430
Issue number3
DOIs
Publication statusPublished - Jan 18 2013

Fingerprint

Aicardi Syndrome
Cathepsin D
Lymphocytes
RNA Interference
Interferon-alpha
Aspartic Acid Endopeptidases
Brain
RNA
Cerebrospinal fluid
RNA Probes
Cathepsins
Neurology
Demyelinating Diseases
Microarray Analysis
Microarrays
Lymphocyte Activation
Astrocytes
Cerebrospinal Fluid
Microscopy
Microscopic examination

Keywords

  • Aicardi-Goutières Syndrome
  • Cathepsin D
  • De-myelination
  • Interferon-alpha
  • Lymphocytes
  • RNA interference

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Cell Biology
  • Molecular Biology

Cite this

Inhibition of the de-myelinating properties of Aicardi-Goutières Syndrome lymphocytes by cathepsin D silencing. / Pulliero, A.; Marengo, B.; Longobardi, M.; Fazzi, E.; Orcesi, S.; Olivieri, I.; Cereda, C.; Domenicotti, C.; Balottin, U.; Izzotti, A.

In: Biochemical and Biophysical Research Communications, Vol. 430, No. 3, 18.01.2013, p. 957-962.

Research output: Contribution to journalArticle

@article{bb9841f646b14990a99d3a61abec88a1,
title = "Inhibition of the de-myelinating properties of Aicardi-Gouti{\`e}res Syndrome lymphocytes by cathepsin D silencing",
abstract = "Molecular mechanisms relating interferon-alpha (IFN-alpha) to brain damage have recently been identified in a microarray analysis of cerebrospinal fluid lymphocytes from patients with Aicardi-Gouti{\`e}res Syndrome (AGS). These findings demonstrate that the inhibition of angiogenesis and the activation of neurotoxic lymphocytes are the major pathogenic mechanisms involved in the brain damage consequent to elevated interferon-alpha levels. Our previous study demonstrated that cathepsin D, a lysosomal aspartyl endopeptidase, is the primary mediator of the neurotoxicity exerted by AGS lymphocytes. Cathepsin D is a potent pro-apoptotic, neurotoxic, and demyelinating protease if it is not properly inhibited by the activities of leukocystatins. In central nervous system white matter, demyelination results from cathepsin over-expression when not balanced by the expression of its inhibitors. In the present study, we used RNA interference to inhibit cathepsin D expression in AGS lymphocytes with the aim of decreasing the neurotoxicity of these cells. Peripheral blood lymphocytes collected from an AGS patient were immortalized and co-cultured with astrocytes in the presence of interferon alpha with or without cathepsin D RNA interference probes. Cathepsin D expression was measured by qPCR, and neurotoxicity was evaluated by microscopy. RNA interference inhibited cathepsin D over-production by 2.6-fold (P",
keywords = "Aicardi-Gouti{\`e}res Syndrome, Cathepsin D, De-myelination, Interferon-alpha, Lymphocytes, RNA interference",
author = "A. Pulliero and B. Marengo and M. Longobardi and E. Fazzi and S. Orcesi and I. Olivieri and C. Cereda and C. Domenicotti and U. Balottin and A. Izzotti",
year = "2013",
month = "1",
day = "18",
doi = "10.1016/j.bbrc.2012.11.131",
language = "English",
volume = "430",
pages = "957--962",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Inhibition of the de-myelinating properties of Aicardi-Goutières Syndrome lymphocytes by cathepsin D silencing

AU - Pulliero, A.

AU - Marengo, B.

AU - Longobardi, M.

AU - Fazzi, E.

AU - Orcesi, S.

AU - Olivieri, I.

AU - Cereda, C.

AU - Domenicotti, C.

AU - Balottin, U.

AU - Izzotti, A.

PY - 2013/1/18

Y1 - 2013/1/18

N2 - Molecular mechanisms relating interferon-alpha (IFN-alpha) to brain damage have recently been identified in a microarray analysis of cerebrospinal fluid lymphocytes from patients with Aicardi-Goutières Syndrome (AGS). These findings demonstrate that the inhibition of angiogenesis and the activation of neurotoxic lymphocytes are the major pathogenic mechanisms involved in the brain damage consequent to elevated interferon-alpha levels. Our previous study demonstrated that cathepsin D, a lysosomal aspartyl endopeptidase, is the primary mediator of the neurotoxicity exerted by AGS lymphocytes. Cathepsin D is a potent pro-apoptotic, neurotoxic, and demyelinating protease if it is not properly inhibited by the activities of leukocystatins. In central nervous system white matter, demyelination results from cathepsin over-expression when not balanced by the expression of its inhibitors. In the present study, we used RNA interference to inhibit cathepsin D expression in AGS lymphocytes with the aim of decreasing the neurotoxicity of these cells. Peripheral blood lymphocytes collected from an AGS patient were immortalized and co-cultured with astrocytes in the presence of interferon alpha with or without cathepsin D RNA interference probes. Cathepsin D expression was measured by qPCR, and neurotoxicity was evaluated by microscopy. RNA interference inhibited cathepsin D over-production by 2.6-fold (P

AB - Molecular mechanisms relating interferon-alpha (IFN-alpha) to brain damage have recently been identified in a microarray analysis of cerebrospinal fluid lymphocytes from patients with Aicardi-Goutières Syndrome (AGS). These findings demonstrate that the inhibition of angiogenesis and the activation of neurotoxic lymphocytes are the major pathogenic mechanisms involved in the brain damage consequent to elevated interferon-alpha levels. Our previous study demonstrated that cathepsin D, a lysosomal aspartyl endopeptidase, is the primary mediator of the neurotoxicity exerted by AGS lymphocytes. Cathepsin D is a potent pro-apoptotic, neurotoxic, and demyelinating protease if it is not properly inhibited by the activities of leukocystatins. In central nervous system white matter, demyelination results from cathepsin over-expression when not balanced by the expression of its inhibitors. In the present study, we used RNA interference to inhibit cathepsin D expression in AGS lymphocytes with the aim of decreasing the neurotoxicity of these cells. Peripheral blood lymphocytes collected from an AGS patient were immortalized and co-cultured with astrocytes in the presence of interferon alpha with or without cathepsin D RNA interference probes. Cathepsin D expression was measured by qPCR, and neurotoxicity was evaluated by microscopy. RNA interference inhibited cathepsin D over-production by 2.6-fold (P

KW - Aicardi-Goutières Syndrome

KW - Cathepsin D

KW - De-myelination

KW - Interferon-alpha

KW - Lymphocytes

KW - RNA interference

UR - http://www.scopus.com/inward/record.url?scp=84872497530&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872497530&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2012.11.131

DO - 10.1016/j.bbrc.2012.11.131

M3 - Article

C2 - 23261460

AN - SCOPUS:84872497530

VL - 430

SP - 957

EP - 962

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 3

ER -